Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 20/20 | 0.89 |
| ▸ | CDK2 | P24941 | 20/20 | 0.89 |
| ▸ | CCNE2 | O96020 | 19/20 | 0.89 |
| ▸ | CDK4 | P11802 | 13/20 | 0.64 |
| ▸ | CCND1 | P24385 | 12/20 | 0.64 |
| ▸ | CDK1 | P06493 | 10/20 | 0.59 |
| ▸ | CCNB2 | O95067 | 9/20 | 0.59 |
| ▸ | CCNB1 | P14635 | 9/20 | 0.59 |
| ▸ | CCNB3 | Q8WWL7 | 9/20 | 0.59 |
| ▸ | CCND2 | P30279 | 1/20 | 0.59 |
| ▸ | CCND3 | P30281 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4991701 | 0.94 | CCNE1 (1.00) | CCNE1CDK2CCNE2CDK4CCND1 | |
| SCHEMBL5216840 | 0.79 | CCNE1 (0.67) | CCNE1CDK2CCNE2CDK4CCND1 | |
| SCHEMBL7514415 | 0.75 | CDK2 (0.52) | CCNE1CDK2CCNE2CDK4CCND1 | |
| SCHEMBL6695938 | 0.75 | CCNE2 (0.76) | CCNE1CDK2CCNE2CDK4CCND1 | |
| SCHEMBL5213819 | 0.74 | CCNE2 (1.00) | CCNE1CDK2CCNE2CDK4CCND1 | |
| SCHEMBL4734684 | 0.74 | CCNE2 (1.00) | CCNE1CDK2CCNE2CDK4CCND1 | |
| SCHEMBL4731497 | 0.73 | CDK2 (1.00) | CCNE1CDK2CCNE2CDK4CCND1 | |
| SCHEMBL14040956 | 0.73 | CCNE2 (0.83) | CCNE1CDK2CCNE2CDK4CCND1 | |
| SCHEMBL5213493 | 0.71 | CCNE2 (0.80) | CCNE1CDK2CCNE2CDK4CCND1 | |
| SCHEMBL16731888 | 0.71 | CCNE1 (0.68) | CCNE1CDK2CCNE2CDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1240153-A1 | AMINOTHIAZOLE INHIBITORS OF CYCLIN DEPENDENT KINASES | Bristol-Myers Squibb Company (US) | 2002-09-18 | — | — | EP | disclosed |
| WO-2001044217-A1 | AMINOTHIAZOLE INHIBITORS OF CYCLIN DEPENDENT KINASES | BRISTOL-MYERS SQUIBB CO. (US) | 2001-06-21 | — | — | WO | disclosed |